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30Different exploratory and conﬁrmatory factorial analyses of the Positive and Negative Syndrome Scale (PANSS)
31have found a number of factors other than the original positive, negative, and general psychopathology. Based on
32a review of previous studies and using conﬁrmatory factor analyses (CFA), Wallwork et al. (Schizophr Res 2012;
33137: 246–250) have recently proposed a consensus ﬁve-factor structure of the PANSS. This solution includes a
34cognitive factor which could be a useful measure of cognition in schizophrenia. Our objectives were 1) to
35study the psychometric properties (factorial structure and reliability) of this consensus ﬁve-factor model of
36the PANSS, and 2) to study the relationship between executive performance assessed using the Wisconsin
37Card Sorting Test (WCST) and the proposed PANSS consensus cognitive factor (composed by items
38P2-N5-G11). This cross-sectional study included a ﬁnal sample of 201 Spanish outpatients diagnosed with
39schizophrenia. For our ﬁrst objective, CFAwas performed and Cronbach's alphas of the ﬁve factors were calculat-
40ed; for the second objective, sequential linear regression analyses were used. The results of the CFA showed ac-
41ceptable ﬁt indices (NNFI=0.94, CFI=0.95, RMSEA=0.08). Cronbach's alphas of the ﬁve factorswere adequate.
42Regression analyses showed that this ﬁve-factor model of the PANSS explainedmore of theWCST variance than
43the classical three-factor model. Moreover, higher cognitive factor scores were associatedwith worseWCST per-
44formance. These results supporting its factorial structure and reliability provide robustness to this consensus
45PANSS ﬁve-factormodel, and indicate someusefulness of the cognitive factor in the clinical assessment of schizo-
46phrenic patients.
47© 2012 Published by Elsevier B.V.
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50
51
52 1. Introduction
53 Already from the earlier descriptions of schizophrenia, cognitive def-
54 icits have been considered to be a core symptom of the disorder
55(Kraepelin, 1919; Bleuler, 1950). Cognitive impairments have been
56found not only in chronic schizophrenic patients (Reichenberg, 2010),
57but also in those with a ﬁrst psychotic episode (Albus et al, 1996;
58Mohamed et al., 1999; Addington et al., 2003), patients in clinical remis-
59sion (Asarnow and MacCrimmon, 1978; Nuechterlein et al., 1992),
60neuroleptic-naïve patients (Saykin et al., 1994; Torrey, 2002), and even
61in subjects at high risk for developing psychosis (Erlenmeyer-Kimling
62and Cornblatt, 1978; Nuechterlein, 1983; Cornblatt et al., 1992) and in
63healthy siblings of schizophrenic patients (Kuha et al., 2007). This cogni-
64tive deﬁcit has considerable relevance regarding prognosis, since it has
65been shown to be an important predictor of functioning in schizophrenia
66(Green, 1996; Velligan et al., 1997; Harvey et al., 1998; Green et al, 2000;
67Bowie and Harvey, 2005; Bowie et al., 2006, 2008).
68Among the cognitive functions that have been shown to be
69impaired in schizophrenic patients, executive functions may be of
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70 special relevance (Joyce et al., 2005). Several studies suggests there
71 may be subgroups of patients based on cognitive performance, with
72 some patients exhibiting speciﬁc impairments in executive functions
73 but preserved general intellectual function (Heinrichs and Awad,
74 1993; Goldstein and Shermansky, 1995; Weickert et al., 2000), and
75 others suffering general intellectual impairments from illness onset,
76 including executive dysfunction (Kremen et al., 1998; Weickert
77 et al., 2000; Fuller et al., 2002). It has been proposed that executive
78 impairments may be considered to be a core deﬁcit in schizophrenia,
79 whatever other cognitive deﬁcits may be present (Joyce et al., 2005).
80 The importance of executive functions has also been noted in some
81 studies that have highlighted their relevance regarding functional
82 outcomes (Martínez-Arán et al., 2002; Reed et al., 2002; Rocca et al.,
83 2009; Penadés et al., 2010), and suggested their potential use as a
84 diagnostic criterion for schizophrenia (Keefe and Fenton, 2007;
85 Peña et al., 2011). Thus, the neuropsychological assessment of schizo-
86 phrenic patients is of great interest for clinicians. In real-life clinical
87 practice, however, resources and time are often insufﬁcient to carry
88 out a complete neuropsychological evaluation.
89 The Positive and Negative Syndrome Scale (PANSS) is a widely used
90 instrument for the clinical assessment of schizophrenic patients. In its
91 original form, itwas divided in three scales: positive, negative and general
92 psychopathology (Kay et al., 1987). Later factorial analyses, however,
93 have pointed to the existence of other components. Five-factor solutions
94 have been the most frequently described (Kay and Sevy, 1990; Lépine,
95 1991; Lindstrom and von Knorring, 1993; Bell et al., 1994a; Kawasaki et
96 al., 1994; Lindenmayer et al., 1994, 1995; Dollfus and Petit, 1995;
97 Fredrikson et al., 1997; Marder et al., 1997; White et al., 1997;
98 Higashima et al., 1998; Lançon et al., 2000; Lykouras et al., 2000; Mass
99 et al., 2000; Wolthaus et al., 2000; El Yazaji et al., 2002; Drake et al.,
100 2003; Emsley et al., 2003; Lee et al., 2003; Fresán et al., 2005; Tirupati
101 et al., 2006; van den Oord et al., 2006; van der Gaag et al., 2006; Levine
102 and Rabinowitz, 2007; Citrome et al., 2011), with factors commonly
103 labeled as ‘positive’, ‘negative’, ‘cognitive’, ‘depression’ and ‘excitement’.
104 The cognitive factor (sometimes called ‘disorganization’) refers to
105 the patient's cognitive functioning, and is composed of several PANSS
106 items that vary partially in the different factorial analyses. If this cogni-
107 tive factor were proved to be valid, obtaining information on cognitive
108 performance using the PANSS would be very valuable given the wide
109 use of this instrument in clinical practice. In this respect, several studies
110 to date have examined the concurrent validity of the PANSS cognitive
111 factor in schizophrenic patients (Bell et al., 1994b; Bryson et al., 1999;
112 Mass et al., 2000; Harvey et al., 2001; Cameron et al., 2002; Daban
113 et al., 2002; Bozikas et al., 2004; Ehmann et al., 2004; Good et al.,
114 2004; Hofer et al., 2007). A ﬁrst study by Bell et al. (1994b) studied the
115 validity of the cognitive factor in 147 patients diagnosed with schizo-
116 phrenic or schizoaffective disorder by examining correlations between
117 this factor and different neuropsychological tests. They found a signiﬁ-
118 cant negative correlation between cognitive factor scores and perfor-
119 mance in all the neuropsychological tests. Based on their results, the
120 authors concluded that the cognitive component of the PANSS is a
121 valid measure of cognitive deﬁcits in schizophrenia. Since then, other
122 similar studies have been carried out, with some obtaining results
123 comparable to those of Bell et al. (1994b), and other studies having
124 less consistent ﬁndings (Hofer et al., 2007). In general correlations
125 between the PANSS cognitive factor and neuropsychological measures
126 have been found to be moderate, ranging between 0.20 and 0.53
127 (Bryson et al., 1999; Cameron et al., 2002; Daban et al., 2002; Bozikas
128 et al., 2004; Good et al., 2004; Hofer et al., 2007).
129 This variability may be due to the use of different neuropsychologi-
130 cal tasks, to the study of different cognitive functions (sometimes
131 grouped in a general cognitive index), or to the use of generalmeasures
132 of cognition such as those derived from the WAIS (Wallwork et al.,
133 2012). However, grouping different cognitive measures in a single
134 cognitive index may mask signiﬁcant correlations of speciﬁc cognitive
135 domains if the remaining domains are not correlated or only weakly
136so. Consequently, it would be desirable to study the concurrent validity
137of the PANSS cognitive factor with each of the cognitive functions that
138are impaired in schizophrenia separately. On other hand, the variability
139in correlations between the PANSS cognitive factor and neuropsycho-
140logical measures may also be due to the fact that the cognitive factors
141used in the different studies are not composed of the same items.
142Despite the general similarity of ﬁve-factor models, none of them has
143achieved broad consensus. In this respect, the different cognitive factors
144described in the literature include a number of items ranging from 3
145(Kay and Sevy, 1990; Lançon et al., 2000; Mass et al., 2000) to 9
146(Citrome et al., 2011). Wallwork et al. (2012) have recently proposed
147a new consensus model, extending previous work by Lehoux et al.
148(2009). They used a larger collection of PANSS ﬁve-factor models
149reported in the literature, and tested and reﬁned the consensus model
150with conﬁrmatory factor analysis (CFA) in an American and in a
151Japanese sample. The consensus cognitive factor proposed by
152Wallwork et al. (2012) is only made up of three PANSS items: ‘Concep-
153tual disorganization’ (P2), ‘Difﬁculty in abstract thinking’ (N5), and
154‘Poor attention’ (G11). If this proposed consensus ﬁve-factor model
155shows adequate psychometric properties in other samples, it would
156gain robustness and could encourage a more generalized use. In addi-
157tion, if this cognitive factor, with only three PANSS items, could provide
158some information regarding the cognitive function of patients, it could
159be of some usefulness in clinical settings. To our knowledge, no studies
160have addressed this issue to date.
161The present study had two objectives:
1621. To study the psychometric properties (factorial structure and reli-
163ability) of the ﬁve-factor model of PANSS proposed byWallwork et
164al. (2012) in a large sample of clinically stable schizophrenic
165patients.
1662. To study the concurrent validity of the cognitive factor proposed in
167this ﬁve-factor model using a neuropsychological task of executive
168function.
1692. Methods
1702.1. Sample
171The present cross-sectional study was carried out with 215 clini-
172cally stable outpatients aged 18 to 60 years, who were consecutively
173referred by their treating psychiatrists. The sample was recruited in
174two of the participating centers (Hospital Universitario 12 de
175Octubre, Madrid and Hospital Virgen de la Luz, Cuenca). All patients
176had been diagnosed with schizophrenia according to DSM-IV criteria
177(APA, 1994), using the Structured Clinical Interview for DSM-IV Axis I
178Disorders (SCID-I) (First et al., 1995). Of the initial sample, 14 patients
179declined participation, leaving a ﬁnal sample of 201 (138 male, 63 fe-
180male). All patients were on antipsychotic treatment and had been
181clinically stable (no hospital admissions, no changes in treatment,
182no signiﬁcant psychopathological changes) for at least 6 months be-
183fore inclusion. The scales and neuropsychological tests used are part
184of the usual clinical protocol, and written informed consent was
185obtained from all participants prior to their inclusion in the study.
186Two experienced neuropsychologists who were blind to PANSS rat-
187ings carried out cognitive assessments. Analysis of interrater reliabil-
188ity indicated an adequate degree of agreement between researchers
189(weighted kappa for PANSS scores: 0.69–0.78).
1902.2. Instruments
1912.2.1. The Positive and Negative Syndrome Scale (PANSS)
192The Positive and Negative Syndrome Scale (Kay et al., 1987; Span-
193ish validation by Peralta and Cuesta, 1994) is a 30-item scale designed
194to obtain a measure of positive (items P1 to P7) and negative (items
195N1 to N7) symptoms in schizophrenic patients, as well as a measure
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196 of general psychopathology (items G1 to G16). Different studies have
197 carried out factorial analyses of the scale, and have found a cognitive
198 factor composed of several items, which partly vary in the different
199 analyses (for a review, see Lehoux et al., 2009). The ﬁve-factor
200 model proposed byWallwork et al. (2012) comprises a positive factor
201 (items P1, P3, P5, G9) a negative factor (items N1, N2, N3, N4, N6, G7),
202 a disorganized/concrete (cognitive) factor (items P2, N5, G11), an ex-
203 cited factor (items P4, P7, G8, G14) and a depressed factor (items G2,
204 G3, G6), including a total of 20 items.
205 2.2.2. The Wisconsin Card Sorting Test (WCST)
206 The Wisconsin Card Sorting Test is a cognitive task that predomi-
207 nantly assesses executive function, and was chosen since this is the
208 most widely applied test of executive performance in schizophrenic
209 patients (Nieuwenstein et al., 2001). The task consists of 64 cards with
210 ﬁgures varying in shape (triangle, circle, square, cross), color (red,
211 blue, green, yellow) and number of ﬁgures (one, two, three, four). Sub-
212 jects have tomatch each of their cards in turnwith one of the 4 stimulus
213 cards presented, on the basis of a rule which the subject does not know
214 andmust learn according to the examiner's feedback (‘right’ or ‘wrong’).
215 When 10 consecutive responses are correct, the rule is changed, and the
216 subject must learn the new rule based on the feedback. The test is over
217 when the subject achieves 6 series or categories, or when 128 trials
218 have been completed. Thenumber of categories completed, thepercent-
219 age of perseverative errors and the percentage of perseverative
220 responses were considered as executive function variables in the pres-
221 ent study (similar to Nieuwenstein et al., 2001). Factor-analytical ﬁnd-
222 ings indicate that these variables load on perseveration, one of the
223 three factors of the WCST, which has been reported to differentiate
224 well between schizophrenic patients and normal subjects (Cuesta
225 et al., 1995; Koren et al., 1998).
226 2.3. Statistical analysis
227 Themean and standard deviation (SD)were used to describe contin-
228 uous variables, while percentages were used for categorical variables.
229 To perform the CFAs, the data was screened to determine the ap-
230 propriate model estimation method. The normalized estimate of
231 Mardia's coefﬁcient of multivariate kurtosis (Mardia, 1970) indicated
232 signiﬁcant non-normality in the data (Bentler and Wu, 1995). Ac-
233 cordingly, the heterogeneous kurtosis (HK) estimator was used. The
234 geometric mean approach to HK model estimation was employed
235 (Bentler et al., 1991). The variance–covariance matrix was the basis
236 of the analyses and the metric of the latent factors was deﬁned by set-
237 ting factor variances to 1.0.
238 Models assessed by CFA are considered to have adequate ﬁt when
239 the Comparative Fit Index (CFI) and the Non-Normed Fit Index
240 (NNFI) are greater than 0.90 and the Root Mean Square Errors of Ap-
241 proximation (RMSEA) is less than 0.08 (Kline, 2010). The Akaike In-
242 formation Criterion (AIC) is included because it allows for
243 comparison between models, with lower values indicating better rel-
244 ative ﬁt.
245 Cronbach's alphas of the ﬁve factors were calculated in order to
246 explore internal consistency.
247 Sequential linear regression analyses were performed to study the
248 relationship between the cognitive factor and the executive function
249 task, with WCST scores as dependent variables. In a ﬁrst step, the
250 inﬂuence of age and gender were controlled for. In a second step, the
251 different PANSS factors of both Wallwork et al.'s (2012) ﬁve-factor/
252 20-item model and of the original three-factor/30-item model were
253 included.
254 The CFAs were performed with EQS (version 6.1) software (Bentler,
255 1995; Bentler and Wu, 1995). All other analyses were performed using
256 the SPSS version 15.0 for Windows statistical package.
2573. Results
2583.1. Patient characteristics, PANSS scores, and neuropsychological
259performance
260The mean age of our sample was 38.0 years (SD: 9.7), and themean
261agewhen they suffered their ﬁrst psychotic episodewas 22.8 years (SD:
2625.5). On their ﬁrst psychiatric admission, patients had been 25.9 (SD:
2636.8) years old, and the mean number of previous hospitalizations was
2642.9 (SD: 3.1). The predominant subtype of schizophrenia in our sample
265was paranoid (86.3%), and in 89.8% the antipsychotic received was an
266atypical.
267Mean scores were 11.9 (SD: 6.1) in the PANSS positive, 18.4 (SD:
2688.4) in the PANSS negative, and 27.7 (SD: 9.3) in the PANSS general
269psychopathology subscale.
270The mean WCST scores obtained by the sample of schizophrenic
271patients were as follows: completed categories 3.5 (SD: 2.2), percent-
272age of perseverative errors 26.1 (SD: 18.0), percentage of persevera-
273tive responses 31.3 (SD: 24.5).
2743.2. Conﬁrmatory factor analysis
275Fit indices showed the ﬁve-factor model of 20 items (Χ2=425.14,
276d.f.=160; RMSEA=0.09; CFI=0.93; NNFI=0.91; AIC=105.14) to ﬁt
277the data better than the three-factor model of 30 items (Χ2=2009.17,
278d.f.=402; RMSEA=0.14; CFI=0.75; NNFI=0.73; AIC=1205.17).
279The ﬁve-factor/20 item model was further improved by adding pa-
280rameters using the Lagrange Multiplier (LM) test (Byrne, 2006). The
281LM test suggested to include correlations between N2 and N4 item er-
282rors (r=0.36, pb0.001), and between G7 and N6 item errors (r=0.35,
283pb0.001) in the model. The ﬁnal model showed acceptable ﬁt indices
284(Χ2=335.71, d.f.=158; RMSEA=0.08; CFI=0.95; NNFI=0.94; AIC=
28519.71). Standardized factor loadings and correlations between factors
286are presented in Tables 1 and 2 respectively. Fig. 1 shows CFA of the
287ﬁve-factor model of the PANSS.
2883.3. Internal consistency
289Cronbach's alphas of the ﬁve factors are presented in Table 2.
Table 1 t1:1
t1:2Five-factor model of the PANSS standardized estimates of regression weights.
t1:3Positive
factor
Negative
factor
Disorganized/concrete
(cognitive) factor
Excited
factor
Depressed
factor
R2
t1:4P1 0.88 0.78
t1:5G9 0.73 0.53
t1:6P3 0.59 0.35
t1:7P5 0.39 0.15
t1:8N3 0.87 0.76
t1:9N1 0.85 0.73
t1:10N2 0.78 0.61
t1:11N6 0.76 0.57
t1:12N4 0.75 0.57
t1:13G7 0.58 0.33
t1:14N5 0.76 0.57
t1:15P2 0.67 0.45
t1:16G11 0.64 0.41
t1:17P4 0.63 0.40
t1:18G14 0.56 0.31
t1:19P7 0.54 0.29
t1:20G8 0.41 0.17
t1:21G3 0.79 0.63
t1:22G6 0.77 0.59
t1:23G2 0.62 0.38
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F290 3.4. Regression analysis
291 Regression analyses for both the ﬁve- and the three-factor models
292 revealed that the greater the age of patients, the poorer the WCST
293 performance, while gender was not found to inﬂuence executive per-
294 formance (see Table 3). Considering the high correlations between in-
295 dependent variables (see Supplementary material) we checked
296 for multicollinearity for each regression analysis and found no
297 multicollinearity in our data (VIFb10, Tolerance>0.02) (Field, 2009).
298In the ﬁve-factor model, higher cognitive factor scores were signiﬁ-
299cantly associated with fewer WCST completed categories (β=−0.33,
300pb0.01) and a greater percentage of perseverative responses (β=0.21,
301pb0.05), and exhibited a trend towards a greater percentage of persev-
302erative errors (β=0.19, p=0.06). Signiﬁcant relationships were also
303found between the depressed factor and all the WCST variables, so that
304the higher the depressed factor scores, the better theWCSTperformance.
305In the classic three-factor model higher negative PANSS scores were
306found to be signiﬁcantly associated with a poorer WCST performance.
307Finally, regression analyses found that the ﬁve-factor model
308explained a greater proportion of the variance of WCST categories
309(16% vs. 11%), percentage of perseverative errors (10% vs. 6%) and
310percentage of perseverative responses (10% vs. 6%) than the classic
311three-factor model.
3124. Discussion
313In the present study, our ﬁrst objective was to examine the psycho-
314metric properties of the ﬁve-factor model of PANSS proposed by
315Wallwork et al. (2012). Our CFA with a sample from a different
316socio-cultural milieu found that their proposed ﬁve-factor/20-item
317model ﬁts our data better than the original PANSS three-factor/30-item
318model. Exclusion of items with low factor saturation or with similar sat-
319uration on several factors would account for this better ﬁt of the 20-item
Table 2t2:1
t2:2 Correlations between the ﬁve factors included in the CFA. The last column shows
t2:3 Cronbach's alpha for each factor.
t2:4 1. 2. 3. 4. 5. Cronbach's
alpha
t2:5 1. Positive factor – 0.36⁎⁎⁎ 0.44⁎⁎⁎ 0.37⁎⁎⁎ 0.38⁎⁎⁎ 0.74
t2:6 2. Negative factor – 0.68⁎⁎⁎ 0.28⁎⁎ 0.26⁎⁎ 0.90
t2:7 3. Disorganized/concrete
(cognitive) factor
– 0.78⁎⁎⁎ 0.31⁎⁎ 0.83
t2:8 4. Excited factor – 0.34⁎ 0.59
t2:9 5. Depressed factor – 0.76
⁎ pb0.05.t2:10
⁎⁎ pb0.01.t2:11
⁎⁎⁎ pb0.001.t2:12
Fig. 1. Diagram showing CFA of the consensus ﬁve-factor model of the PANSS. F1: Positive factor, F2: Negative factor, F3: Disorganized/concrete (cognitive) factor, F4: Excited factor,
F5: Depressed factor. Standardized Loadings and standard errors are shown over unidirectional lines, while correlations are shown beside bidirectional lines. Signiﬁcance at
*pb0.05, **pb0.01 and ***pb0.001.
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320 model. In addition, we introduced two post-hoc speciﬁcations that were
321 suggested by the LM test in order to improve themodel. The inclusion of
322 correlations between the errors of two pairs of items of the negative
323 factor (N2 “emotional withdrawal”–N4 “passive/apathetic social with-
324 drawal”, and N6 “lack of spontaneity”–G7 “motor retardation”) could
325 be related with a possible overlap between the content of the items in
326 each pair (Aish and Joreskog, 1990; Byrne, 2006). Moreover, in a previ-
327 ous study van der Gaag et al. (2006) carried out CFA of the PANSS and
328 found that N2 (emotional withdrawal) and N4 (passive/apathetic social
329 withdrawal) errors were correlated in 10 out of 10 analyses performed.
330 This supports the inclusion in the model of the correlation between N2
331 and N4 errors. However, to our knowledge, previous studies have not in-
332 cluded correlations between N6 and G7 scores, suggesting the need to
333 replicate this result in independent samples. Regarding the comparison
334 of our CFA with that carried out by Wallwork et al. (2012), although
335 some of the standardized loadings of the items differed slightly between
336 our study andWallwork's (e.g. P5: 0.39 vs. 0.74; N5: 0.76 vs. 0.41), all of
337 themwere salient (i.e.,≥0.30, according to Brown, 2006). The CFA indi-
338 ces obtained in our ﬁnal model (Χ2=335.71, RMSEA=0.08; CFI=0.95;
339 NNFI=0.94; AIC=19.71) were similar to those of Wallwork's study
340 (Χ2=290.43, RMSEA=0.09; CFI=0.95; NNFI=0.96; AIC=174.43 in
341 the U. S. sample, and Χ2=153.81, RMSEA=0.13; CFI=0.94; NNFI=
342 0.97; AIC=67.81 in the Japanese sample).
343 The internal consistencies (Cronbach's alphas) for the ﬁve-factor
344 model ranged from 0.59 (excited factor) to 0.90 (negative factor).
345 Though the excited factor's internal consistency is below the widely
346 accepted 0.70 cutoff, it is close to 0.60, an acceptable alpha cutoff for
347 brief scales (i.e. those with fewer than 10 items) (Loewenthal, 1996).
348 Moreover, high Cronbach's alphas could indicate the presence of redun-
349 dant items in a scale. The fact that the negative factor exhibits a
350 Cronbach's alpha coefﬁcient of 0.90, includes a greater number of
351 items, and the content of some of them (N2–N4, N6–G7) may partly
352overlap suggests that reducing the number of items in this factor may
353be desirable. Taking into account that the PANSS is a semi-structured
354interview which is commonly used by clinicians, a briefer scale could
355facilitate its use in the clinical context, and future research should ex-
356plore this possibility.
357In summary, the psychometric properties found in our study
358support the ﬁve-factor/20-item model proposed by Wallwork et al.
359(2012), which exhibits acceptable factorial structure indices and reli-
360ability in a large sample of patients with schizophrenia from a differ-
361ent socio-cultural context.
362The second objective of our study was to examine the relationship
363between the ﬁve-factor model cognitive factor and neuropsychologi-
364cal variables of executive function in a large sample of schizophrenic
365patients. In order to control for covariation between different PANSS
366factors, and to ﬁnd differential associations between the ﬁve PANSS
367factors and WCST scores, regression analyses were performed. Our
368results show that higher cognitive factor scores were signiﬁcantly
369associated with poorer executive function as assessed by the WCST.
370When applied to the classical three-factormodel, the regression anal-
371ysis revealed a signiﬁcant association between higher negative subscale
372scores and poorer performance on the WCST. Since Crow (1980) pro-
373posed his two-syndrome model, in which schizophrenic patients with
374most cognitive impairment were those with predominantly negative
375symptoms, different authors have studied the relationship between the
376negative and cognitive dimensions of schizophrenia. Cross-sectional
377studies have generally found a correlation between negative and cogni-
378tive symptoms, with several studies having speciﬁcally investigated the
379relationship between executive function and symptom dimensions in
380schizophrenia. A meta-analysis carried out by Nieuwenstein et al.
381(2001) found a signiﬁcant relationship between WCST performance
382and negative symptoms, although the observed association was weak;
383amore recentmeta-analysis byDibben et al. (2009) found an association
384between executive dysfunction andnegative symptoms, although the ef-
385fect size was small. It could be hypothesized that part of the association
386between the negative PANSS subscale of the original three-factor
387model and executive function found in the literature could be due to
388the fact that the different PANSS factors (especially the cognitive factor)
389were not considered. In this respect, our ﬁndings indicate that when
390moving from the three-factor model to the ﬁve-factor model, the associ-
391ation between WCST performance and the negative factor disappears,
392and a relationship with the cognitive factor emerges.
393Regarding the relationship observed between the depressed factor
394in the ﬁve-factor model and executive function, it could be speculated
395that patients with a greater affective component may exhibit better ex-
396ecutive performance. However, the fact that no correlationswere found
397between the depressed factor and WCST variables (see Supplementary
398material) suggests that the relationship observed in the regression anal-
399yses could be due to a statistical artifact known as suppression effect. In
400multiple regression, suppression describes a situation in which a pre-
401dictor variable that is uncorrelatedwith the outcome variable neverthe-
402less adds signiﬁcantly to its prediction when other predictor variables
403that are correlated with the initial predictor are included in the regres-
404sion equation. The additional predictor variables essentially suppress
405outcome-irrelevant variance in the ﬁrst predictor, allowing it to more
406efﬁciently predict the outcome variable (for a detailed discussion of
407suppression effects, see Paulhus et al., 2004).
408In a global comparison between both models, the ﬁve-factor model
409explained a greater proportion of the variance of the cognitive variables
410than did the three-factor model, even though the ﬁve-factor model in-
411cluded 10 items less. In any case, despite the signiﬁcant relationships
412between the ﬁve-factor model and the WCST, the variance explained
413by the ﬁve factors does not exceed 16%. This is in agreement with pre-
414vious studies suggesting that although the PANSS cognitive factor may
415provide information regarding the cognitive status of the patient, it can-
416not replace formal neuropsychological assessments (Harvey et al.,
4172001; Hofer et al., 2007).
Table 3t3:1
t3:2 Stepwise linear regression analyses with WCST scores as dependent variables and
t3:3 PANSS a) ﬁve-factor model and b) three-factor model factors as independent variables.
t3:4 a) Five-factor model Dependent variables (WCST)
t3:5 Independent
variables
Categories Perseverative
errors
Perseverative
responses
t3:6 β ΔR2 β ΔR2 β ΔR2
t3:7 Step
1
Age −0.22⁎⁎ 0.06⁎ 0.16⁎ 0.03 0.17⁎ 0.03⁎
t3:8 Gender 0.10 −0.06 −0.06
t3:9 Step
2
Positive factor −0.04 0.16⁎⁎⁎ 0.02 0.10⁎⁎ 0.02 0.10⁎⁎
t3:10 Negative factor −0.14 0.11 0.10
t3:11 Disorganized/
concrete
(cognitive) factor
−0.33⁎⁎ 0.19 0.21⁎
t3:12 Excited factor 0.02 0.11 0.09
t3:13 Depressed factor 0.16⁎ −0.17⁎ −0.15⁎
t3:14
t3:15 b) Three-factor model Dependent variables (WCST)
t3:16 Independent
variables
Categories Perseverative
errors
Perseverative
responses
t3:17 β ΔR2 β ΔR2 β ΔR2
t3:18 Step
1
Age −0.22⁎⁎ 0.06⁎⁎ 0.16⁎ 0.03 0.17⁎ 0.03⁎
t3:19 Gender 0.10 −0.06 −0.06
t3:20 Step
2
Positive
dimension
−0.10 0.11⁎⁎⁎ 0.04 0.06⁎⁎ 0.03 0.06⁎⁎
t3:21 Negative
dimension
−0.37⁎⁎⁎ 0.15⁎ 0.26⁎
t3:22 General
psychopathology
0.12 −0.03 −0.09
⁎ pb0.05.t3:23
⁎⁎ pb0.01.t3:24
⁎⁎⁎ pb0.001.t3:25
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418 Our study focused on executive function, which is one of the main
419 cognitive functions that have been found to be impaired in schizo-
420 phrenic patients (Pantelis et al., 1997; Hutton et al., 1998; Rhinewine
421 et al., 2005). This impairment has been related to structural and
422 functional brain anomalies in regions that are thought to be involved
423 in the pathophysiology of schizophrenia such as the prefrontal cortex
424 (Eisenberg and Berman, 2010), and to alterations in the dopaminergic
425 system (Robbins and Arnsten, 2009). However, despite its relevance,
426 the use of a single cognitive domain could be a limitation of the present
427 study, and it would be interesting to replicate this research including
428 other cognitive functions, such asmemory or attention, that are also im-
429 paired in schizophrenia.
430 To conclude, the fact that the data obtained from an independent
431 sample of Spanish schizophrenic patients ﬁts the ﬁve-factor/20-item
432 model reasonably well supports the factorial structure of this consensus
433 model proposed byWallwork et al. (2012). This fact togetherwith the re-
434 liability indices and concurrent validity data obtainedprovides robustness
435 to the model. Nevertheless, although the cognitive factor could provide
436 useful information about patients for whom formal neuropsychological
437 testing is unavailable in the clinical setting, the proportion of the variance
438 that is explained by the ﬁve-factor model of the PANSS makes it
439 unadvisable to substitute neuropsychological assessment with the
440 PANSS cognitive factor when studying cognition in schizophrenia.
441 Supplementary data to this article can be found online at http://
442 dx.doi.org/10.1016/j.schres.2012.10.020.
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